Simcere Pharmaceutical Group (SCR)

9.25 -0.04  -0.43%  May 21, 5:01PM
Add to Watchlists Create an Alert

Simcere Pharmaceutical Group Liabilities:

218.04M for Dec. 31, 2012
View Full Chart

Simcere Pharmaceutical Group Liabilities Chart

    Simcere Pharmaceutical Group Historical Liabilities Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 218.04M
    Sept. 30, 2012 217.76M
    June 30, 2012 227.68M
    March 31, 2012 257.94M
    Dec. 31, 2011 265.96M
    Sept. 30, 2011 235.96M
    June 30, 2011 218.68M
    March 31, 2011 203.78M
    Dec. 31, 2010 202.59M
    Sept. 30, 2010 171.20M
    June 30, 2010 154.92M
    March 31, 2010 164.16M
    Dec. 31, 2009 169.52M
       
    Sept. 30, 2009 93.13M
    June 30, 2009 91.55M
    March 31, 2009 72.27M
    Dec. 31, 2008 77.08M
    Sept. 30, 2008 83.41M
    June 30, 2008 85.89M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro

    About Total Liabilities

    Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

    Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

    Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

    Simply, liabilities are the part of a company's assets that it has yet to repay back.
    Learn More

    Get data for

    SCR Liabilities Benchmarks

    Companies
    Bristol-Myers Squibb 22.30B
    Merck
    Sagent Pharmaceuticals 42.89M

    SCR Liabilities Rankings

    Overall 68th percentile
    2554 of 8002
    Sector 30th percentile
    472 of 684 in Healthcare
    Industry 26th percentile
    50 of 68 in Drug Manufacturers - Specialty & Generic

    SCR Liabilities Range, Past 5 Years

    Minimum 72.27M Mar 2009
    Maximum 265.96M Dec 2011
    Average 169.03M